Subsense Inc.

Honored to be joining the panel “Neurotech Now: Rewiring the Future of Brain Health” at Device Talks West on Thursday, Oct. 15 at 10:45-11:30 am with Cognito Therapeutics, Inc. Chief Medical Officer Ralph Kern I’ll be discussing the origin of Subsense Inc., our nanoparticle-based, non-surgical brain computer interface and potential applications for patients but also for healthy individuals as well. The future in this space is very exciting and we’ll also be exploring how BCI technology can be an everyday technology like your smartphone.  #Neurotechnology#BCI 

2 weeks later and we’re still overjoyed with gratitude and thankful to everyone who joined us to celebrate a milestone for both Subsense and the broader #BCI community with the opening of our Palo Alto lab. Guests experienced demos, toured the lab and listened to thought leaders who made up a truly diverse panel discussing the most exciting developments shaping the future of brain-computer interfaces. Thank you again to our panelists: Naomi Halas from Rice University, Sergey Stavisky from University of California, Davis, Daniel Palanker from Stanford University, Vikash Gilja from Paradromics, Amy Peck from EndeavorXR and Harvard HealthLab Accelerator, Aaron Vaccaro from Singularity University, and Max de Vere from re.Mind Capital, and to Naveen Rao from Forbes and Neurotech Futures for moderating. Our new lab is a place for bold ideas, technical exploration, and collaboration across disciplines. 📸 For photos from the evening, see below. #BrainComputerInterface #Neurotechnology  

We’re proud to share that our CEO and co-founder, Tetiana Aleksandrova, has been named to BioSpace’s 40 Under 40, recognizing leaders shaping the future of biotech. Tetiana co-founded Subsense to make brain-computer interfaces safe, scalable, and accessible, advancing a nonsurgical, nanoparticle-based approach that redefines what’s possible in neurotechnology. Congratulations, Tetiana, and thank you for inspiring all of us to push the boundaries of human potential. #Neurotechnology #WomenInTech #BCI #BioSpace40Under40 Full list of winners: https://lnkd.in/eB_Xe-eS

We’re excited to welcome Michael Nketiah, MBA, RAC, to Subsense as our new Senior Vice President of Regulatory & Clinical Trials! Michael brings nearly three decades of experience spanning regulatory, clinical, and quality systems across a broad range of medical technologies. His expertise will help us build the foundation to advance our non-surgical, nanoparticle-based brain-computer interface technology toward clinical evaluation. At Subsense, we believe it’s critical to engage with the FDA as early as possible. That’s why we are already beginning this important work to ensure a clear and responsible regulatory path forward. Early dialogue allows us to align expectations, anticipate potential challenges, and ultimately accelerate the safe and ethical delivery of breakthrough neurotechnology to patients. Welcome to the Subsense team, Michael! #Subsense #Neurotechnology #BrainComputerInterface

Subsense CEO and co-founder, Tetiana Aleksandrova, recently shared her thoughts on the benefits for the industry with Sam Altman getting into #BCI, among other billionaires like Elon Musk and Brian Johnson, and what it means for the future of the #neurotech. “For me, their involvement is a good sign. When billionaires step into BCI, they bring visibility and capital that elevate the whole industry. Suddenly, more funds are planning to allocate resources to neurotechnology, more companies are founded, and more engineers discover that this is an exciting space worth dedicating their careers to.” You can read more from Tetiana in Decrypt's story from Jason Nelson.  https://lnkd.in/gRyZDTdE

The future of brain-computer interfaces is not built in isolation. It takes conversation, collaboration, and a community that is ready to challenge assumptions. Last week, we opened the doors to our new lab in Palo Alto, and it was inspiring to celebrate alongside so many who are shaping the field of BCI and neurotechnology. Guests joined for interactive demos, a panel of leading experts, and an evening of ideas that reminded us what is possible when disciplines come together. Thank you to our speakers and to everyone who joined us. This lab is designed as a space for bold exploration, and the energy from our opening night sets the tone for what is to come. See highlights from the evening below. #BCI #Neurotech

Thank you to everyone who joined us last night to celebrate a milestone for both Subsense and the broader #BCI community. Guests experienced interactive demos and heard from a truly diverse panel of thought leaders. The conversation touched on the most exciting developments shaping the future of brain-computer interfaces, and reminded us just how expansive and collaborative this field has become. We are grateful to our panelists: Naomi Halas from Rice University, Sergey Stavisky from University of California, Davis, Daniel Palanker from Stanford University, Vikash Gilja from Paradromics, Amy Peck from EndeavorXR and Harvard Health Lab Accelerator, Aaron Vaccaro from Singularity University, Max de Vere from re.Mind Capital, and to Naveen Rao from Forbes and Neurotech Futures for moderating. Our new lab in Palo Alto represents a place for bold ideas, technical exploration, and collaboration across disciplines. The future of BCI is unfolding, and we’re excited to help shape what comes next! #BrainComputerInterface #Neurotechnology  

At Subsense, we’re proud to have our own Tetiana Aleksandrova and Scott Meek, Ph.D. featured in MedicalExpo's story by Erin Tallman for our work developing the world’s first non-surgical, nanoparticle-based brain-computer interface. Our approach aims to combine the precision of invasive BCIs with the accessibility of non-invasive systems without requiring brain surgery. This article highlights the momentum behind our mission: reimagining brain health through safe, scalable technology. 🔗 Read the full article here: https://lnkd.in/gaVMHySw #Neurotechnology #BCI 

The next interface isn’t on your phone or your wrist. It’s in your brain 🧠 In a new Built In op-ed, our own Alexandra Karpman writes about how designing for brain-computer interfaces requires an entirely new design language. It’s the future of human experience, and it’s a future we’re building at Subsense. 🔗 Read Alexandra’s article: https://lnkd.in/gQPmiKd3